AutoICD API

75540-5

Laboratory

Hepatitis A virus RNA+Parvovirus B19 DNA [Interpretation] in Plasma from Donor Qualitative by NAA with probe detection

Definition

Simultaneously detects hepatitis A virus (HAV) RNA (genotypes 1-3) and parvovirus B19 (B19) DNA (genotypes 1-3) in human donor plasma, either from whole blood (recovered plasma) or collected by apheresis, prior to further manufacture. The aim is to reduce the B19 burden and remove HAV from plasma pools. This term represents the composite result of the individual HAV qualitative test and B19 quantitative test. If either result is reactive, the composite result is reactive; otherwise, it is nonreactive. Plasma may be tested as individual specimens or in pools. Not intended for use on samples of cord blood or as an aid in diagnosis. This term was created for, but is not limited in use to, the cobas TaqScreen DPX test kit.

LOINC 6-Axis Classification

Component

Hepatitis A virus RNA+Parvovirus B19 DNA

Property

Imp

Time Aspect

Pt

System

Plas^Donor

Scale Type

Ord

Method Type

Probe.amp.tar

Details

Class

MICRO

Order/Observation

Both

Short Name

HAV RNA+B19V DNA Plas Donr NAA+probe-Imp

Display Name

HAV RNA+Parvovirus B19 DNA NAA+probe Ql (P donor) [Interp]

Related Names

3 Self-Sustaining Sequence Replication3SR SRAmplifAmplificationAmplifiedB19B19 virusB19VDeoxyribonucleic acidDNA NUCLEIC ACID PROBEDNA probeDonrFifth DiseaseHAVHAV RNA+B19VHepHep AHepatisHepatitHepatitisHepatitis AHepatitis type AHepatologyIDImpressionImpression/interpretation of studyImpressionsInfectious DiseaseInfectiousDiseaseInterpInterpretationLATLCRLigase chain reactionLigation-activated transcriptionLiverMicrobiologyNAA+probeNAATNASBANucleic acid sequence based analysisOrdinalParvoParvo virusParvovParvovirus type b19PCRPlPlasmaPlsmPoint in timePolymerase chain reactionProbe ampProbe with ampificationProbe with target amplificationQBRQLQualQualitativeRandomRibonucleic acidScreenSDAStrand Displacement AmplificationTMATranscription mediated amplification

Frequently Asked Questions

What is LOINC code 75540-5?

LOINC code 75540-5 identifies "Hepatitis A virus RNA+Parvovirus B19 DNA [Interpretation] in Plasma from Donor Qualitative by NAA with probe detection". Simultaneously detects hepatitis A virus (HAV) RNA (genotypes 1-3) and parvovirus B19 (B19) DNA (genotypes 1-3) in human donor plasma, either from whole blood (recovered plasma) or collected by apheresis, prior to further manufacture. The aim is to reduce the B19 burden and remove HAV from plasma pools. This term represents the composite result of the individual HAV qualitative test and B19 quantitative test. If either result is reactive, the composite result is reactive; otherwise, it is nonreactive. Plasma may be tested as individual specimens or in pools. Not intended for use on samples of cord blood or as an aid in diagnosis. This term was created for, but is not limited in use to, the cobas TaqScreen DPX test kit.

What does 75540-5 measure?

This code measures Hepatitis A virus RNA+Parvovirus B19 DNA in Plas^Donor. It belongs to the MICRO class in the LOINC classification.

What is LOINC?

LOINC (Logical Observation Identifiers Names and Codes) is a universal standard for identifying laboratory and clinical observations. It is maintained by the Regenstrief Institute and used worldwide for health data exchange.